Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia
Br J Haematol
.
2020 Aug;190(4):e187-e189.
doi: 10.1111/bjh.16954.
Epub 2020 Jul 9.
Authors
Julien Favresse
1
2
,
Christine Eucher
1
,
Marc Elsen
1
,
Carlos Graux
3
,
Paul Goebels
4
,
Kim Laffineur
1
,
Jean-Baptiste Nicolas
5
,
Jean-Michel Dogné
2
,
Jonathan Douxfils
2
6
Affiliations
1
Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
2
Department of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Namur, Belgium.
3
Department of Hematology, CHU UCL Namur, Yvoir, Belgium.
4
Department of Laboratory Medicine, Saint Nikolaus Hospital, Eupen, Belgium.
5
Department of Internal Medicine, Clinique St-Luc Bouge, Namur, Belgium.
6
Qualiblood sa, Namur, Belgium.
PMID:
32557555
PMCID:
PMC7323137
DOI:
10.1111/bjh.16954
No abstract available
Keywords:
COVID-19; SARS-CoV-2; kinetics; serology; symptom onset.
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19*
Hospitals
Humans
Kinetics
Leukemia, Lymphocytic, Chronic, B-Cell*
Pandemics
SARS-CoV-2
Substances
Antibodies, Viral